國家衛生研究院 NHRI:Item 3990099045/12914
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 855481      在线人数 : 1144
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/12914


    题名: Association between gout, urate-lowering therapy, and risk of developing type 2 diabetes mellitus: A nationwide population-based retrospective cohort study
    作者: Fang, YJ;Chung, YL;Lin, CL;Lim, YP
    贡献者: National Institute of Environmental Health Sciences;NHRI Graduate Student Program
    摘要: Gout is the most prevalent inflammatory arthritis in adults. Although the link between gout and type 2 diabetes mellitus (T2DM) has been documented, our understanding of the association between urate-lowering therapy (ULT) among gout patients and T2DM development remains poor. We included 69,326 patients with new-onset gout in 2000-2011. Each case was matched randomly with 1 patient without gout during the study period, and 69,326 patients were recognized as the comparison cohort. A Cox proportional hazard regression model was used to analyze differences in the risk of T2DM development between patients with and without gout after considering related comorbidities. After adjusting for potential confounders, the case group had a higher risk of T2DM than the control cohort (adjusted hazard ratio oaHRTHORN = 1:30, 95%confidence interval oCITHORN = 1:24-1.38; P < 0:001). Gout patients without appropriate ULT had significantly higher risk of T2DM development than the control cohort (aHR = 1:39; 95%CI = 1:30-1.48; P < 0:001). Among gout patients, those receiving ULT excluding probenecid (aHR = 0:80; 95% CI = 0:64-1.00), all had significantly lower risk of T2DM than gout patients without ULT (all aHR < 0:90; all P < 0: 001). In this study, we found that gout increased the risk of T2DM; however, patients with any ULT exhibited a lower risk of T2DM than gout patients without any ULT (all aHR < 0:90, P < 0:001; excluding probenecid).
    日期: 2020-07
    關聯: Biomed Research International. 2020 Jul;2020:Article number 6358954.
    Link to: http://dx.doi.org/10.1155/2020/6358954
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000561369000001
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85089320398
    显示于类别:[其他] 期刊論文
    [其他] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    ISI000561369000001.pdf450KbAdobe PDF249检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈